ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Ms. Aisha: Nose and throat cancer

Patient basic information Patient: Aisha Ms. (Aisha Williams) Nationality: Malaysia Disease Diagnosis: Nose and Throat Cancer Diagnostic Hospital: H0H treatment: Intracellular Treatment + Medicines Accommodation days: 142 days Treatment cost: about 627457 yuan Treatment effect: Pain relief Description: Aisha Ms. is from Malaysia and was diagnosed with Nose Cancer locally.

Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on patient inspection reports and physical conditions, and provided translation, escort and on-site services throughout the treatment process. After 142 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached hospital standards. Treatment results: Patient's final pain relief.

At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient and continued to track recovery through a remote follow-up system. 'Ladies Aisha, experts have criticized this case as a typical cross-border clinical case of suspicious severity. A multi-disciplinary collaborative mechanism for the development of an intravenous treatment + drug program for nostril cancer reflects the comprehensive strength of Chinese hospitals in the field of suspicious diagnostics and a summary of how international medical services are regulated.

马来西亚,鼻咽癌,南京鼓楼医院,国际医疗,来华就医,中国医疗